Stay updated on PCSK9 Inhibitors in HoFH Clinical Trial
Sign up to get notified when there's something new on the PCSK9 Inhibitors in HoFH Clinical Trial page.

Latest updates to the PCSK9 Inhibitors in HoFH Clinical Trial page
- Check6 days agoChange DetectedVersion 2 (2021-08-24) updates the Recruitment Status for NCT04759534. The record history shows a change in the study's recruitment status.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check35 days agoChange DetectedUpdated operating status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference13%

- Check42 days agoChange DetectedThe page has been updated from Revision: v3.0.2 to Revision: v3.1.0.SummaryDifference0.3%

- Check56 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2; the Back to Top link was removed.SummaryDifference0.8%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.8%

- Check70 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms have been removed.SummaryDifference5%

Stay in the know with updates to PCSK9 Inhibitors in HoFH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PCSK9 Inhibitors in HoFH Clinical Trial page.